Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
This star-forming galaxy is blowing out powerful winds topping 2 million mph - 2These HGTV stars made a pledge to keep their kids off smartphones. Here's how it's going.
- 3Nature: 10 High priority Setting up camp Spots In Europe
- 4Figure out How to Ascertain the Restitution Time frame for Your Sunlight based chargers
- 5Dominating Monetary Administration: A Bit by bit Manual for Making an Individual Financial plan
- Figure out How to Store Your Gold Ventures: A Thorough Aide safely
- China and Pakistan issue five-point peace plan for Middle East
- The most effective method to Guarantee Scholastic Honesty in Web-based Degrees
- What is IDF's view on pontential long-term occupation of southern Lebanon?
- 5 Affordable Travel Destinations To Visit In South America
- Getting ready for a Mechanized World: 10 Positions That computer based intelligence Could Dominate
- Chinese astronauts’ return to Earth delayed over fears spaceship damaged by debris
- 12 Once-In-A-Lifetime Travel Experiences To Add to Your Bucket List
- Israel’s 'Stonehenge’ not alone with near 30 similar sites, satellite imagery reveals
